Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 200.53 Million USD | 0.0% |
| 2023 | 84.22 Thousand USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 57.19 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 200.53 Million USD | 0.0% |
| 2024 Q2 | 180.77 Million USD | 0.0% |
| 2024 FY | 200.53 Million USD | 237992.46% |
| 2023 FY | 84.22 Thousand USD | 0.0% |
| 2023 Q4 | 84.22 Thousand USD | 0.0% |
| 2023 Q2 | 126.33 Thousand USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q2 | 46.78 Thousand USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | 57.19 Thousand USD | 0.0% |
| 2020 Q4 | 57.19 Thousand USD | 0.0% |
| 2020 Q2 | 170.25 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -181.564% |
| Alkermes plc | 287.73 Million USD | 30.304% |
| Agenus Inc. | 137.32 Million USD | -46.031% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 91.441% |
| Aptorum Group Limited | 3.05 Million USD | -6456.67% |
| Ardelyx, Inc. | 51.54 Million USD | -289.035% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -91.702% |
| Bicycle Therapeutics plc | 40.08 Million USD | -400.339% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -99.344% |
| ChromaDex Corporation | 2.57 Million USD | -7687.796% |
| Chimerix, Inc. | 125 Thousand USD | -160328.606% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -6091.992% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -674.03% |
| CRISPR Therapeutics AG | 223 Million USD | 10.076% |
| Precision BioSciences, Inc. | 7.72 Million USD | -2496.604% |
| Dyadic International, Inc. | 88.87 Thousand USD | -225550.679% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -911426.173% |
| Fortress Biotech, Inc. | 60.85 Million USD | -229.525% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -325995.613% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -5175.868% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -222410.938% |
| Incyte Corporation | 29.16 Million USD | -587.661% |
| IO Biotech, Inc. | 1.83 Million USD | -10804.609% |
| Jaguar Health, Inc. | 30.99 Million USD | -547.036% |
| Novavax, Inc. | 168.01 Million USD | -19.355% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -770.948% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -3384.548% |
| ContextLogic Inc. | 6 Million USD | -3242.263% |
| MiMedx Group, Inc. | 48.09 Million USD | -316.923% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -897.74% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -523615.124% |
| NextCure, Inc. | 5.94 Million USD | -3270.915% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -138200.523% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -806.95% |
| PDS Biotechnology Corporation | 19.5 Million USD | -928.063% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -73.654% |
| Pharming Group N.V. | 166.1 Million USD | -20.728% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -3127.68% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -498.346% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -16528.172% |
| Acelyrin, Inc. | 1.19 Million USD | -16695.29% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -43494.73% |
| Summit Therapeutics Inc. | 103.29 Million USD | -94.148% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -5220.662% |
| Senti Biosciences, Inc. | 33.53 Million USD | -497.936% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -4101.462% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -480.321% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -232.448% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -12672.978% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -689.387% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -92.198% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -27295.595% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1691.938% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -44.996% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -1392.193% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1236.905% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -5.03% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -280.827% |
| Fortress Biotech, Inc. | 60.85 Million USD | -229.525% |
| Precigen, Inc. | 5.89 Million USD | -3301.794% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -377.603% |
| AlloVir, Inc. | 16.64 Million USD | -1104.564% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -204.965% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -105.973% |
| ImmuCell Corporation | 10.54 Million USD | -1802.527% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -17725.401% |
| Onconetix, Inc. | 118.85 Thousand USD | -168620.191% |
| PureTech Health plc | 18.25 Million USD | -998.826% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -202461.372% |
| Elevation Oncology, Inc. | 30.13 Million USD | -565.414% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -672.361% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -367.733% |
| Innoviva, Inc. | 446.23 Million USD | 55.06% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -23973.921% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -299905.622% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 3.108% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -181.667% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -6190.331% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -19219.437% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -798.216% |
| Aptose Biosciences Inc. | 621 Thousand USD | -32192.393% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -19736.682% |
| Century Therapeutics, Inc. | 46.65 Million USD | -329.799% |
| Kura Oncology, Inc. | 9.33 Million USD | -2048.904% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -651.07% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -145215.767% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -2036.769% |
| Autolus Therapeutics plc | 47.91 Million USD | -318.533% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -3987.561% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -2860.811% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -53.479% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -2374.223% |
| IGM Biosciences, Inc. | 34.67 Million USD | -478.38% |
| INmune Bio, Inc. | 397 Thousand USD | -50412.785% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -15.414% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4846.297% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -136366.228% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -302.909% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -267.484% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -338.876% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 57.636% |
| Verastem, Inc. | 40.08 Million USD | -400.264% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -4455.56% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1894.587% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -2956.482% |
| Histogen Inc. | 4.38 Million USD | -4474.265% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -22636.48% |
| Organovo Holdings, Inc. | 888 Thousand USD | -22482.856% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -568.453% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -4681.492% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -961.317% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -164.909% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -215288.982% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -674.06% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -75007.025% |
| Amarin Corporation plc | 8.73 Million USD | -2195.247% |
| Mesoblast Limited | 100.48 Million USD | -99.572% |
| Turnstone Biologics Corp. | 1.18 Million USD | -16765.917% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -156.017% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -183877.76% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -144.529% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -5.576% |
| Better Therapeutics, Inc. | 10.34 Million USD | -1837.918% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -767.182% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -115.553% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -15421.343% |
| Gritstone bio, Inc. | 40.14 Million USD | -399.541% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10954.893% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -30.563% |
| Insmed Incorporated | 1.19 Billion USD | 83.196% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -3058.043% |
| OmniAb, Inc. | 22.07 Million USD | -808.429% |
| Alector, Inc. | 30.45 Million USD | -558.444% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -97.487% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -2392.056% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 52.992% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1088.712% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -252.473% |
| Immunic, Inc. | 639 Thousand USD | -31282.748% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -572.51% |
| Veracyte, Inc. | 7.52 Million USD | -2564.927% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 68.903% |
| FibroGen, Inc. | 89.69 Million USD | -123.57% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4523.836% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -153140.991% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 96.074% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -541888.535% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -10028.069% |
| TG Therapeutics, Inc. | 100.11 Million USD | -100.299% |
| Galecto, Inc. | 66 Thousand USD | -303742.058% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -147352.763% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 87.715% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -3233.928% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3615.689% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10954.893% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -835.029% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -448.586% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -38688.348% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -343.31% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -555.903% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -347.604% |
| Vaxxinity, Inc. | 13.26 Million USD | -1412.108% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 75.281% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -44557.481% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -2181.668% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.581% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -63360.683% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -4398.335% |
| Ainos, Inc. | 5.92 Million USD | -3286.538% |
| Pluri Inc. | 29.05 Million USD | -590.241% |
| Prothena Corporation plc | 10.72 Million USD | -1770.495% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -910.205% |
| Celularity Inc. | 26.17 Million USD | -666.076% |
| Rallybio Corporation | 173 Thousand USD | -115816.623% |
| Cue Biopharma, Inc. | 4.2 Million USD | -4672.388% |
| MeiraGTx Holdings plc | 72.11 Million USD | -178.062% |
| Omeros Corporation | 329.7 Million USD | 39.177% |
| Humacyte, Inc. | 38.6 Million USD | -419.523% |
| Immunocore Holdings plc | 82.64 Million USD | -142.65% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -12332.471% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -5506.255% |
| Blueprint Medicines Corporation | 610.96 Million USD | 67.177% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -13654.167% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -110.671% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -311.913% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -120.609% |
| Pulmatrix, Inc. | 8.32 Million USD | -2308.259% |
| Elicio Therapeutics, Inc. | 6 Million USD | -3238.368% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -1449.137% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -107.279% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -42658.157% |
| Cytokinetics, Incorporated | 607.37 Million USD | 66.983% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -2207.13% |
| Nutriband Inc. | 79.82 Thousand USD | -251116.093% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -4372.252% |
| Vor Biopharma Inc. | 31.83 Million USD | -530.021% |
| Roivant Sciences Ltd. | 477.85 Million USD | 58.034% |
| Evogene Ltd. | 10.65 Million USD | -1782.435% |
| ProKidney Corp. | 3.61 Million USD | -5455.007% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -26321.048% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -761640.325% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 88.446% |
| CorMedix Inc. | 517.01 Thousand USD | -38687.372% |
| BioLineRx Ltd. | 6.62 Million USD | -2925.585% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -444.372% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -179.527% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1218.36% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -23705.6% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -78541.474% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -364.741% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -48732.552% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -14548.339% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -30142.205% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -12.616% |
| Biomea Fusion, Inc. | 7.83 Million USD | -2461.121% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 29.442% |
| Mereo BioPharma Group plc | 5.3 Million USD | -3683.694% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -9227.245% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -34004.721% |
| Absci Corporation | 4.66 Million USD | -4203.342% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1640.46% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -783.612% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1904.355% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1643.031% |
| Allakos Inc. | 38.21 Million USD | -424.757% |
| Imunon, Inc. | 1.13 Million USD | -17501.772% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -2223.974% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -23887.531% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -2005257.58% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -126.989% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -4158.564% |
| XOMA Corporation | 118.51 Million USD | -69.203% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1891.615% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -440.834% |
| aTyr Pharma, Inc. | 13.76 Million USD | -1356.641% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -2438.749% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -703.3% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -892.506% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -1336805.053% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -71985.897% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1287.324% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 86.624% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -147165.433% |
| UroGen Pharma Ltd. | 98.55 Million USD | -103.484% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -34.485% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -951.743% |
| Entera Bio Ltd. | 256 Thousand USD | -78234.28% |
| GH Research PLC | 631 Thousand USD | -31680.627% |
| Lisata Therapeutics, Inc. | 137.00 USD | -146376365.693% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -31136.099% |
| Xencor, Inc. | 14.64 Million USD | -1269.593% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -133367.17% |
| Replimune Group, Inc. | 71.99 Million USD | -178.561% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -133590.505% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -2762.343% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -147165.433% |
| Portage Biotech Inc. | 7000.00 USD | -2864696.543% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -30142.205% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -13933.293% |
| OncoCyte Corporation | 2.2 Million USD | -8998.719% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -299632.095% |
| Purple Biotech Ltd. | 163 Thousand USD | -122928.072% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -7810.681% |
| scPharmaceuticals Inc. | 38.81 Million USD | -416.698% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -694.39% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -274606.518% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -10722.221% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -661.104% |
| Curis, Inc. | 1.48 Million USD | -13367.815% |
| Daré Bioscience, Inc. | 3.91 Million USD | -5023.974% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -28641.787% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -3342162.633% |
| BeiGene, Ltd. | 197.61 Million USD | -1.476% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -21900.632% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -148.881% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -286.471% |
| bluebird bio, Inc. | 224.41 Million USD | 10.642% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 66.188% |
| DBV Technologies S.A. | 4.52 Million USD | -4330.75% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -14865.355% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -1958.466% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -5223.487% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 46.845% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -367.7% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -11579.427% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -21509.457% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1048.084% |
| MacroGenics, Inc. | 30.19 Million USD | -564.114% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1032.778% |
| Prime Medicine, Inc. | 4.35 Million USD | -4502.611% |
| Aditxt, Inc. | 1.04 Million USD | -19150.004% |
| Adagene Inc. | 13.54 Million USD | -1381.058% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1359.822% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 61.339% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1073.204% |
| SciSparc Ltd. | 24 Thousand USD | -835465.658% |
| Vericel Corporation | 81.85 Million USD | -144.986% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -144.506% |
| Generation Bio Co. | 89.77 Million USD | -123.378% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -803.925% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 0.626% |
| Invivyd, Inc. | 722 Thousand USD | -27675.036% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -313.459% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -6858801.403% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -5142.765% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -871794.6% |
| 2seventy bio, Inc. | 244.01 Million USD | 17.818% |
| ADMA Biologics, Inc. | 130.59 Million USD | -53.557% |
| Clene Inc. | 7.15 Million USD | -2703.912% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -5839.585% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 19.014% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -18113.965% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -76188.497% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -4.11% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -606.037% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1980.462% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -79.574% |
| Evaxion Biotech A/S | 8.48 Million USD | -2262.371% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -167.649% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -209.875% |
| Trevena, Inc. | 35.23 Million USD | -469.17% |
| Surrozen, Inc. | 882 Thousand USD | -22636.48% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -3126.122% |
| Cingulate Inc. | 135.09 Thousand USD | -148336.153% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -751.93% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -319.531% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -111308.754% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -690.164% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1050.059% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -21324.76% |
| Statera Biopharma, Inc. | 11.43 Million USD | -1654.294% |
| ImmunityBio, Inc. | 836.95 Million USD | 76.04% |
| Korro Bio, Inc. | 31.21 Million USD | -542.413% |
| Kineta, Inc. | 150 Thousand USD | -133590.505% |
| BioVie Inc. | 349.89 Thousand USD | -57213.289% |
| Codexis, Inc. | 12.24 Million USD | -1537.963% |
| Celularity Inc. | 26.17 Million USD | -666.076% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -321.692% |
| Celcuity Inc. | 37.03 Million USD | -441.47% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -113617.859% |
| Cibus, Inc. | 17.67 Million USD | -1034.637% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -5834.766% |
| Kodiak Sciences Inc. | 100 Million USD | -100.536% |
| Annexon, Inc. | 29.19 Million USD | -587.002% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -210.297% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -17773.062% |
| Avalo Therapeutics, Inc. | 2 Million USD | -9926.788% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 85.68% |
| Eyenovia, Inc. | 8.95 Million USD | -2138.814% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -205.42% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -2362.979% |
| Arcellx, Inc. | 50.84 Million USD | -294.437% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -13654.167% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -844.231% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -18908.129% |
| Moolec Science SA | 99.04 Thousand USD | -202367.296% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -626.026% |
| Geron Corporation | 35.05 Million USD | -472.126% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -33831.6% |
| Royalty Pharma plc | 6.13 Billion USD | 96.731% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -12112.896% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -631667.872% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -766.32% |
| Humacyte, Inc. | 38.6 Million USD | -419.523% |
| Structure Therapeutics Inc. | 4.01 Million USD | -4897.153% |
| 89bio, Inc. | 24.79 Million USD | -708.775% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -1512.802% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -10646.825% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -19331.759% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -101.527% |
| Notable Labs, Ltd. | 1.52 Million USD | -13041.269% |
| Liquidia Corporation | 2.36 Million USD | -8382.9% |
| Mustang Bio, Inc. | 1.97 Million USD | -10038.309% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1359.822% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -2784.162% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -63160.491% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -302.061% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1988.044% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -306112.888% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -147352.763% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -3101.401% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -154158.275% |
| PepGen Inc. | 17.1 Million USD | -1072.724% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -42207.122% |
| United Therapeutics Corporation | 300 Million USD | 33.155% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -737.625% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -4717.268% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -34594.768% |
| XOMA Corporation | 118.51 Million USD | -69.203% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -541888.535% |
| Bionomics Limited | 117.62 Million USD | -70.483% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -21393.65% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3474.612% |
| uniQure N.V. | 130.06 Million USD | -54.181% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -242.27% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -29132.618% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4523.836% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -14379.116% |
| Altimmune, Inc. | 175 Thousand USD | -114491.862% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 48.297% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3474.612% |
| Compugen Ltd. | 719 Thousand USD | -27790.926% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -3858.463% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -137.166% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1919.494% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -3043.686% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -119.381% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1919.494% |
| Instil Bio, Inc. | 81.42 Million USD | -146.277% |
| argenx SE | 15.35 Million USD | -1206.082% |
| Immunome, Inc. | 1.34 Million USD | -14865.355% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -37313.388% |
| Verona Pharma plc | 48.37 Million USD | -314.553% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -2075.952% |
| Shattuck Labs, Inc. | 3.4 Million USD | -5787.72% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -235824.421% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -119266.523% |
| Moolec Science SA | 99.04 Thousand USD | -202367.296% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1717.753% |
| AnaptysBio, Inc. | 16.03 Million USD | -1150.457% |
| Design Therapeutics, Inc. | 2.33 Million USD | -8491.935% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -740677.06% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -3242.263% |
| Achilles Therapeutics plc | 1.07 Million USD | -18537.152% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -2075.952% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1005797.663% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1097.77% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -251116.093% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -2687686.597% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1542482.754% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 41.446% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -719.048% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -7921.462% |
| Palisade Bio, Inc. | 90 Thousand USD | -222717.509% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -103268.947% |
| Beam Therapeutics Inc. | 159.91 Million USD | -25.405% |
| Neurogene Inc. | 13.37 Million USD | -1399.557% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 34.555% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -663.568% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -335120.752% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -19953.576% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -395.052% |
| Athira Pharma, Inc. | 1.21 Million USD | -16377.877% |
| Vaccinex, Inc. | 26 Thousand USD | -771191.377% |
| HCW Biologics Inc. | 6.3 Million USD | -3080.927% |
| XOMA Corporation | 118.51 Million USD | -69.203% |
| Nektar Therapeutics | 112.62 Million USD | -78.056% |
| Arvinas, Inc. | 800 Thousand USD | -24966.97% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1287.324% |
| Merus N.V. | 10.48 Million USD | -1812.05% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1247.234% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -1393.304% |
| Rezolute, Inc. | 1.66 Million USD | -11980.467% |
| Clene Inc. | 7.15 Million USD | -2703.912% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -273303.171% |
| BeyondSpring Inc. | 3.36 Million USD | -5861.229% |
| Synlogic, Inc. | 12.49 Million USD | -1505.442% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -514.085% |
| Krystal Biotech, Inc. | 6.62 Million USD | -2929.241% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -17.328% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -3244.492% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -423230.219% |
| MannKind Corporation | 252.15 Million USD | 20.47% |
| Ikena Oncology, Inc. | 7.18 Million USD | -2692.977% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -100671.738% |
| Gossamer Bio, Inc. | 197.4 Million USD | -1.586% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -38464.569% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 28.718% |
| Mural Oncology plc | 8.91 Million USD | -2150.429% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -358.514% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -13864.886% |
| Champions Oncology, Inc. | 6.09 Million USD | -3191.248% |
| REGENXBIO Inc. | 82.22 Million USD | -143.895% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -40494.036% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -4422.683% |
| Vaxart, Inc. | 2.62 Million USD | -7545.282% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -73726.536% |
| Cellectis S.A. | 36.24 Million USD | -453.339% |
| Longeveron Inc. | 1.44 Million USD | -13749.155% |
| Repare Therapeutics Inc. | 1.01 Million USD | -19755.026% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 82.293% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -347.934% |
| Revolution Medicines, Inc. | 80.57 Million USD | -148.881% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -6151.115% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -113197.038% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -162937.202% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 72.328% |
| Denali Therapeutics Inc. | 44.98 Million USD | -345.823% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -1503.741% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -148336.153% |
| Passage Bio, Inc. | 22.92 Million USD | -774.9% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -3220.678% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -30894.708% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -894.474% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -40825.665% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -49116.422% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -16780.114% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -42933.424% |
| OmniAb, Inc. | 22.07 Million USD | -808.429% |
| Anew Medical, Inc. | 1.54 Million USD | -12921.802% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -578.403% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -2120.035% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -545.017% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4846.297% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -288.959% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -3049.611% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1319.32% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -29741.631% |
| Alumis Inc. Common Stock | 30.86 Million USD | -549.824% |
| Equillium, Inc. | 384 Thousand USD | -52122.854% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -3155.979% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -32.762% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -310.27% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -166593.619% |
| Dominari Holdings Inc. | 3.02 Million USD | -6522.713% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1014089.845% |
| vTv Therapeutics Inc. | 169 Thousand USD | -118560.212% |
| Bio-Techne Corporation | 319 Million USD | 37.136% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -251.891% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -12.303% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1201.589% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -1519.444% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -4071.744% |
| Nkarta, Inc. | 82.27 Million USD | -143.753% |
| BioCardia, Inc. | 982 Thousand USD | -20321.157% |
| Iterum Therapeutics plc | 18.95 Million USD | -957.901% |